Amphastar Pharmaceuticals, Inc. (AMPH) vs Harrow Health, Inc. (HROW)
A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Harrow Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMPH
Amphastar Pharmaceuticals, Inc.
$25.13HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
HROW
Harrow Health, Inc.
$29.89HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — AMPH vs HROW
growth of $100 · dividends reinvested · last 10yAMPH +32.8% (+2.9%/yr)HROW +761.4% (+24.0%/yr)HROW compounded faster over this window
Log scale — wide-divergence pair
AMPH HROW
AMPH vs HROW: by the numbers
- •HROW is the larger company ($1.11B vs $1.11B market cap).
- •AMPH is profitable (10.76% net margin) while HROW runs a net loss (-13.51%).
- •HROW grew revenue faster over the past five years (34.52% vs 13.71% CAGR).
Metrics side by side
Valuation
| Metric | AMPH | HROW |
|---|---|---|
| P/E ratio | 14.87 | N/A |
| Forward P/E | 8.46 | N/A |
| PEG ratio | 0.11 | N/A |
| P/S ratio | 1.52 | 4.04 |
| P/B ratio | 1.44 | 73.30 |
| EV / EBITDA | 8.76 | N/A |
| FCF yield | 13.80% | 0.48% |
Profitability
| Metric | AMPH | HROW |
|---|---|---|
| Gross margin | 47.68% | 73.28% |
| Operating margin | 15.66% | 14.18% |
| Net margin | 10.76% | -13.51% |
| ROE | 10.23% | -244.91% |
| ROIC | 5.93% | 1.81% |
Growth (annualized)
| Metric | AMPH | HROW |
|---|---|---|
| Revenue CAGR (5Y) | 13.71% | 34.52% |
| EPS CAGR (5Y) | 134.23% | N/A |
| FCF CAGR (5Y) | 23.90% | N/A |
| Total return CAGR (5Y) | 6.13% | 27.66% |
Frequently asked
- Which has grown faster, AMPH or HROW?
- Over the past five years, HROW grew revenue faster — AMPH at a 13.71% CAGR versus HROW at 34.52%.
- Is AMPH or HROW more profitable?
- AMPH runs the higher net margin — AMPH at 10.76% versus HROW at -13.51%.
- How have AMPH and HROW total returns compared?
- Over the past 10 years, AMPH delivered 2.47% and HROW delivered 23.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amphastar Pharmaceuticals P/E ratioAmphastar Pharmaceuticals ROEHarrow Health ROEAmphastar Pharmaceuticals operating marginHarrow Health operating marginAmphastar Pharmaceuticals revenue growthHarrow Health revenue growthAmphastar Pharmaceuticals free cash flowHarrow Health free cash flow
Amphastar Pharmaceuticals & Harrow Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.